Ulthera is an aesthetic company that develops and markets ultrasound-based technology to tighten, lift and rejuvenate the skin.
The company’s system is the only FDA-cleared procedure to non-invasively lift the eyebrow, neck and under-chin. Ulthera puts great emphasis on clinical evidence, product quality and customer service, and it provides extensive training to practitioners.
At the time of Apposite’s investment, Ulthera’s product was approved in Europe and about to receive FDA clearance. The company has since undergone spectacular growth becoming a leading player globally. The company’s product became available in over 50 countries and sales were expected to reach $100 million in the year it was sold. The company also continued to expand the application of its technology to other parts of the body and other medical indications, and significantly increase its work force to c150.
The company was sold to Merz in July 2014.